Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Langford

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Best Practice & Research. Clinical Rheumatology|July 27, 2001
Management of systemic vasculitisC A Langford
Cleveland Clinic Journal of Medicine|April 16, 1998
The diagnostic utility of c-ANCA in Wegener's granulomatosisC A Langford
Clinical and Experimental Immunology|March 31, 2011
Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitisC A Langford
The American Journal of the Medical Sciences|February 24, 2001
Wegener granulomatosisC A Langford
Clinical and Experimental Rheumatology|January 29, 2005
Antineutrophil cytoplasmic antibodies should not be used to guide treatment in Wegener's granulomatosisC A Langford
Arthritis and Rheumatism|March 27, 2001
Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: where do we stand?C A Langford
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 1, 1997
Complications of cyclophosphamide therapyC A Langford
Current Opinion in Rheumatology|January 1, 1997
Chronic immunosuppressive therapy for systemic vasculitisC A Langford
American Annals of the Deaf|September 1, 1983
Microcomputers for severely handicapped students: issues in design and evaluationC A Langford, P S Fidler
Current Opinion in Rheumatology|January 1, 1997
New developments in the treatment of Wegener's granulomatosis, polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndromeC A Langford, M C Sneller
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Best Practice & Research. Clinical Rheumatology|July 27, 2001
Management of systemic vasculitisC A Langford
Cleveland Clinic Journal of Medicine|April 16, 1998
The diagnostic utility of c-ANCA in Wegener's granulomatosisC A Langford
Clinical and Experimental Immunology|March 31, 2011
Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitisC A Langford
The American Journal of the Medical Sciences|February 24, 2001
Wegener granulomatosisC A Langford
Clinical and Experimental Rheumatology|January 29, 2005
Antineutrophil cytoplasmic antibodies should not be used to guide treatment in Wegener's granulomatosisC A Langford
Arthritis and Rheumatism|March 27, 2001
Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: where do we stand?C A Langford
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 1, 1997
Complications of cyclophosphamide therapyC A Langford
Current Opinion in Rheumatology|January 1, 1997
Chronic immunosuppressive therapy for systemic vasculitisC A Langford
American Annals of the Deaf|September 1, 1983
Microcomputers for severely handicapped students: issues in design and evaluationC A Langford, P S Fidler
Current Opinion in Rheumatology|January 1, 1997
New developments in the treatment of Wegener's granulomatosis, polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndromeC A Langford, M C Sneller
Pageof 4